Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06092710
Other study ID # OSASSS1
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date January 1, 2023
Est. completion date June 30, 2024

Study information

Verified date February 2024
Source Center for Sleep Medicine - Clinique André Renard
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

the study aims to evaluate the accuracy correlation between subjective perception of the air flow through airways from patients and survey and/or polysomnography they spent, using a brief clinical protocol they answered with a manual therapist


Description:

The subjects in the study are 18 to 77 years old and present the following conditions: - polysomnography and sleep survey realized at the Center for Sleep Medicine André RENARD, without any informations of the results for the experience group - sleep survey with no sleep trouble found for the control group


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 110
Est. completion date June 30, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 77 Years
Eligibility Inclusion Criteria: - Female or male subjects aged 18 to 77 years old - subjects who have performed a PSG at the sleep medicine center André Renard for the study group - subjects with no sleep disorder on sleep survey for the control group - Subjects who agree to comply with the requirements of the study. - Subjects who are of age (and know how to read and write) who have given their informed, explicit consent in advance to any procedure related to the trial, the study or the investigation conducted on human beings, with the objective of developing knowledge specific to the exercise of health care professions, as set out in Royal Decree No. 78 of 10 November 1967 on the practice of the health care professions (Act of 27 December 2005) Exclusion Criteria: - subjects with acute infections - subjects with trauma within the last 72 hours - subjects who already benefit from OSA treatment - subjects with known perceptual disorders, for example post-stroke - subjects with current or recent chemotherapy and radiotherapy treatment - Pregnant women - Criteria related to prior or concurrent treatments: Treatment with antipsychotics, anxiolytics, soporifics or muscle relaxants started within the two months preceding the study. Treatment with intraoral implants during the study or in the two months preceding the study

Study Design


Intervention

Diagnostic Test:
neuro-sensorial subjective evaluation of the airways collapsibility
verbal and manual guidance of subjects from a therapist to experiment the subjective perception of the air flow through their airways and airways collapsibility

Locations

Country Name City State
Belgium Centre de médecine du sommeil- Clinique André Renard Herstal Liège

Sponsors (5)

Lead Sponsor Collaborator
Center for Sleep Medicine - Clinique André Renard CHAKAR Bassam, neurologist, MD, PhD, LACROIX Alain, neurologist, MD, PhD, PIRON Alain, Osteopath - physiotherapist, SELAK Ivan, neurologist, MD, PhD

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary accuracy correlation of a subjective perception of the airways collapsibility protocol between OSA subjects and control subjects to validate a OSA screening tool Evaluation of the subjects perception of the air flow using different positions or maneuvers: their answers are noted as positive, negative, neutral or no response for the air flow perception of ease. their answers are noted as up, down for the position of the tongue into the mouth. their answers are noted as nasal, buccal or mixed about their ventilatory habits. their answers are noted of their supposed frequency of dorsal decubitus, lateral decubitus, ventral decubitus. the investigators note the Friedman and Mallampati stage of the tonsils and velum, then the Angle class of dentition.
All the items will be allotted (+1), (0), or (-1) score to define a global score which will be analyzed by linear correlation coefficient (Pearson's) in relation to the status, with or without OSA, of each subjects.
during the clinical protocol, about 15 to 20 minutes
Secondary predictive value on the severity of OSA of the subjective upper airway collapsibility perception scale Does the precision of the subjective perception scale make it possible to obtain a rating of the factors aggravating or facilitating the passage of air in correlation with the different stages of severity of OSA? the sensitivity and specificity of each element and their overall relevance in relation to the severity stage of OSA. during the examination protocol, about 15 to 20 minutes
Secondary therapeutic material indication tool Are therapeutic proposals and equipment adapted according to the screening results of each item during the neuro-sensory evaluation protocol? suggestion of therapeutic proposal by yes or no: if head position facilitating collapsibility of the upper airways, indication for a medical pillow, if positive mandibular advancement, indications for an mandibular advancement device, if positive nostril spacing, indication for a nasal dilatator, if position on the back aggravates the collapsibility of the upper airways, indication of an anti-supine belt during the clinical protocol, about 15 to 20 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A
Completed NCT02894242 - The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA) N/A